TACI is mutant in common variable immunodeficiency and IgA deficiency

Nature Genetics

Volumn 37, Issue 8, 2005, Pages 829-834

  Castigli, Emanuela ^a   Wilson, Stephen A ^a   Garibyan, Lilit ^a   Rachid, Rima ^a   Bonilla, Francisco ^a   Schneider, Lynda ^a   Geha, Raif S ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; APRIL PROTEIN; B CELL ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY; DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN; RNA; TRANSMEMBRANE ACTIVATOR AND CALCIUM MODULATOR AND CYCLOPHILIN LIGAND INTERACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL;

B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IGA DEFICIENCY; IMMUNOGLOBULINS; LIGANDS; MEMBRANE PROTEINS; MUTATION, MISSENSE; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

EID: 23044463627     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1601     Document Type: Article

References (37)

1. Burrows, P.D. & Cooper, M.D. IgA deficiency. Adv. Immunol. 65, 245-276 (1997).
2. Cunningham-Rundles, C. Physiology of IgA and IgA deficiency. J. Clin. Immunol. 21, 303-309 (2001).
3. Di Renzo, M., Pasqui, A.L. & Auteri, A. Common variable immunodeficiency: a review. Clin. Exp. Med. 3, 211-217 (2004).
4. Kokron, C.M. et al. Clinical and laboratory aspects of common variable immunodeficiency. An. Acad. Bras. Cienc. 76, 707-726 (2004).
5. Schroeder, H.W. Jr. Genetics of IgA deficiency and common variable immunodeficiency. Clin. Rev. Allergy Immunol. 19, 127-140 (2000).
6. Cunningham-Rundles, C., Cooper, D.L., Duffy, T.P. & Strauchen, J. Lymphomas of mucosal-associated lymphoid tissue in common variable immunodeficiency. Am. J. Hematol. 69, 171-178 (2002).
7. Weston, S.A., Prasad, M.L., Mullighan, C.G., Chapel, H. & Benson, E.M. Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed? Clin. Exp. Immunol. 124, 465-469 (2001).
8. Eastwood, D. et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin. Exp. Immunol. 137, 584-588 (2004).
9. Grimbacher, B. et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4, 261-268 (2003).
10. Asano, T. et al. Molecular analysis of B-cell differentiation in selective or partial IgA deficiency. Clin. Exp. Immunol. 136, 284-290 (2004).
11. Kaneko, H. et al. Expression of the alpha-chain gene in heterogeneous IgA immunodeficiency. Scand. J. Immunol. 32, 483-489 (1990).
12. Islam, K.B. et al. Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J. Immunol. 152, 1442-1452 (1994).
13. Schroeder, H.W. Jr., Schroeder, H.W. III & Sheikh, S.M. The complex genetics of common variable immunodeficiency. J. Investig. Med. 52, 90-103 (2004).
14. Grimbacher, B., Schaffer, A.A. & Peter, H.H. The genetics of hypogammaglobulinemia. Curr. Allergy Asthma Rep. 4, 349-358 (2004).
15. Geha, R.S., Jabara, H.H. & Brodeur, S.R. The regulation of immunoglobulin E class-switch recombination. Nat. Rev. Immunol. 3, 721-732 (2003).
16. Litinskiy, M.B. et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822-829 (2002).
17. Castigli, E. et al. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201, 35-39 (2005).
18. Ramesh, N. et al. CD40-CD40 ligand (CD40L) interactions and X-linked hyperIgM syndrome (HIGMX-1). Clin. Immunol. Immunopathol. 76, S208-S213 (1995).
19. Ferrari, S. et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. USA 98, 12614-12619 (2001).
20. Farrington, M. et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc. Natl. Acad. Sci. USA 91, 1099-1103 (1994).
21. Mackay, F. & Kalled, S.L. TNF ligands and receptors in autoimmunity: an update. Curr. Opin. Immunol. 14, 783-790 (2002).
22. MacLennan, I. & Vinuesa, C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17, 235-238 (2002).
23. Gorelik, L. et al. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J. Exp. Med. 198, 937-945 (2003).
24. Schiemann, B. et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293, 2111-2114 (2001).
25. von Bulow, G.U. & Bram, R.J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278, 138-141 (1997).
26. Van, M. et al. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2, 638-643 (2001).
27. Castigli, E. et al. Impaired IgA class switching in APRIL-deficient mice. Proc. Natl. Acad. Sci. USA 101, 3903-3908 (2004).
28. Hendriks, J. et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 12, 637-648 (2005).
29. Ingold, K. et al. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201, 1375-1383 (2005).
30. Cunningham-Rundles, C. & Bodian, C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 92, 34-48 (1999).
31. von Bulow, G.U. et al. Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse. Mamm. Genome 11, 628-632 (2000).
32. Hymowitz, S. et al. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J. Biol. Chem. 280, 7218-7227 (2005).
33. Mackay, F. & Tangye, S. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr. Opin. Pharmacol. 4, 347-354 (2004).
34. Seshasayee, D. et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18, 279-288 (2003).
35. Volanakis, J.E. et al. Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J. Clin. Invest. 89, 1914-1922 (1992).
36. Kralovicova, J., Hammarstrom, L., Plebani, A., Webster, A.D. & Vorechovsky, I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J. Immunol. 170, 2765-2775 (2003).
37. De la Concha, E.G. et al. MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J. Immunol. 169, 4637-4643 (2002).